Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease

Por Liu, Cong, Liao, Jia-Zhi, Li, Pei-Yuan
Publicado no World J Gastroenterol (2017)

The role of autophagy in hepatocellular carcinoma: friend or foe

Por Liu, Lian, Liao, Jia-Zhi, He, Xing-Xing, Li, Pei-Yuan
Publicado no Oncotarget (2017)

MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma

Por Xu, Fei, Liao, Jia‐Zhi, Xiang, Guang‐Ya, Zhao, Peng‐Xuan, Ye, Feng, Zhao, Qiu, He, Xing‐Xing
Publicado no Cancer Med (2017)

Celecoxib alleviates nonalcoholic fatty liver disease by restoring autophagic flux

Por Liu, Cong, Liu, Lian, Zhu, Hai-Dan, Sheng, Jia-Qi, Wu, Xiao-Li, He, Xing-Xing, Tian, De-An, Liao, Jia-Zhi, Li, Pei-Yuan
Publicado no Sci Rep (2018)

The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma

Por Zhao, Juan-Feng, Zhao, Qiu, Hu, Hui, Liao, Jia-Zhi, Lin, Ju-Sheng, Xia, Chao, Chang, Ying, Liu, Jing, Guo, An-Yuan, He, Xing-Xing
Publicado no Mol Ther Nucleic Acids (2018)

MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1

Por Yan, Jing-Jun, Zhang, Yu-Nan, Liao, Jia-Zhi, Ke, Kun-peng, Chang, Ying, Li, Pei-Yuan, Wang, Min, Lin, Ju-Sheng, He, Xing-Xing
Publicado no Oncotarget (2015)

MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma

Por Fan, Yin-Ping, Liao, Jia-Zhi, Lu, Ya-Qi, Tian, De-An, Ye, Feng, Zhao, Peng-Xuan, Xiang, Guang-Ya, Tang, Wang-Xian, He, Xing-Xing
Publicado no Mol Ther Nucleic Acids (2017)

Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma

Por Xue, Hui-Ying, Liu, Yong, Liao, Jia-Zhi, Lin, Ju-Sheng, Li, Bin, Yuan, Wei-Gang, Lee, Robert J., Li, Lei, Xu, Chuan-Rui, He, Xing-Xing
Publicado no Oncotarget (2016)